- Lobbying
- Lobbying by IVX Health
Lobbying Relationship
Bills mentioned
S.2543: Prescription Drug Pricing Reduction Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.19: Lower Costs, More Cures Act of 2019
Sponsor: Greg Walden (R-Ore.)
S.3129: Lower Costs, More Cures Act of 2019
Sponsor: Michael D. Crapo (R-Idaho)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
John McManus | Staff Director, W&M Health Subcommittee; LA, Rep. Bill Thomas. LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
Barrett Thornhill | LA, Sen. Crapo & Rep. Toomey; LA & Press Sec., Rep. Norwood. LA, Sen. Crapo and Rep. Toomey. LA and Press Secretary, Rep. Norwood. |
ALANNA TEMME | LD, Rep. Jon Porter. |
Christina Hochul | n/a |
William Rhyne | n/a |
Paul Cronan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate